The value of new drugs for advanced prostate cancer.
Saved in:
| Title: | The value of new drugs for advanced prostate cancer. |
|---|---|
| Authors: | Howard DH; Department of Health Policy and Management, Emory University, Atlanta, Georgia.; Winship Cancer Institute, Emory Healthcare, Atlanta, Georgia., Quek RGW; Pfizer, Inc, San Francisco, California., Fox KM; Strategic Healthcare Solutions, LLC, Aiken, South Carolina., Arondekar B; Pfizer, Inc, Collegeville, Pennsylvania., Filson CP; Winship Cancer Institute, Emory Healthcare, Atlanta, Georgia.; Department of Urology, Emory University, Atlanta, Georgia. |
| Source: | Cancer [Cancer] 2021 Sep 15; Vol. 127 (18), pp. 3457-3465. Date of Electronic Publication: 2021 Jun 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.33662 |
